CAR-T Cell Therapy from cancer to possible new immunotherapy for Heart Failure. Today discussed at HEART FAILURE 2024, Lisbon.

A new paper by Fudan University scientists supports the potential of M10 CAR-T cells as a novel, safe, and effective therapeutic option for the functional cure of #HIV -1/ #AIDS .

✔️ Read it here:
go.nature.com/3woHnze

Друзья! Моя подруга Лола умирает от рака. В Лондоне ей уже предоставили паллиативную помощь. У нас осталась последняя надежда – «car-T cell therapy» в Китае. Стоимостью £100000, которые нужны уже через 2 недели.
Мы открыли сбор:
gofund.me/c6c44270
Подробности ниже👇🏼

AdAlta (ASX:1AD) adds a second building block to its cellular immunotherapy strategy by signing a Master Services Agreement with Australia's leading contract manufacturer of cellular immunotherapies, Cell Therapies Pty Ltd |
investorhub.adalta.com.au/announcements/…

#CellTherapy #ClinicalTrial

Very pleased with the publication of our new review that captures the latest news on the study of functional integration following the use of cell therapy to repair brain damage. Institut de Neurociències de la UB💉🧠🔬 #BrainDamage
mdpi.com/2787998 #mdpibioengineering via Bioengineering MDPI

🗽New #listing

🌠 $SCT (SuperCells Token)will be listed on LBank！SuperCells

SuperCells is a currency and payment platform for stem cell therapy and beauty.

❤Details: tinyurl.com/338mzb8s

The Patient From Oman Shares His Experience After Stem Cell Therapy for Chronic Hypertension With Knee Osteoarthritis at Stem Cell Care India.
Email id- [email protected]
Ph no- +91 8743024344
#stemcelltherapy , #osteoarthritis #hypertension , #celltherapy , #stemcells ,

A very good friend has been accepted as a candidate for stem cell therapy for his MS. If you had a couple of quid to throw his way I'd be hugely grateful. He's been fighting this for 14 years now, I'd love for there to be some relief.

gofundme.com/f/help-my-fian…

🚨 First patient declared ‘cancer free’ using indigenous CAR-T cell therapy in India, by paying just 42 lakh instead of 4 crore abroad.

Today we announced patient dosing has commenced in a Phase 1 clinical trial of SENTI-202, a potential first-in-class Logic Gated off-the-shelf #CARNK investigational #celltherapy for relapsed/refractory hematologic malignancies including #AML : bit.ly/3yhWWZW

Did u know the AACR Journals has simultaneous publication opportunities? Here's a picture of first author Sumanta K. Pal (Sumanta K. Pal, MD, FASCO) presenting his article that published at #AACR24 .
aacrjournals.org/cancerdiscover…

Actinium will host a KOL call on Monday, May 20 at 8:00 AM ET to provide updates and highlight its recently announced #clinicaltrial to study Iomab-ACT with a leading FDA approved #CART #celltherapy . Details on how to register can be found here: bit.ly/3JSmgsc $ATNM

We're excited to partner with Multiply Labs. Their cutting edge technology will bolster our efforts to add 10 years to healthy human lifespan. Read the press release for more details: businesswire.com/news/home/2024…

Goodie Mob ‘Cell Therapy’ 1995✨ youtu.be/OGy4bmG5SJw?si…

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases

Retro Biosciences says the modular structure of the Multiply Labs robots will help enable Retro to bring its cell therapies to patients. Learn more: ow.ly/jNYK50RGlRc

Special thanks to the Mission Bio team for coming out to interview with us at #ASGCT2024 !

The videos will be found here when they are published👇

cgtlive.com/conferences/am…

Durand et al: Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial

Link: link.springer.com/article/10.100…

Neurocritical Care Society #NeuroCritCare

World Health Summit: “If we had surveyed two years ago…‘Would you be willing to take gene or cell therapy and inject it into your body?’ we would have probably had a 95% refusal rate. I think this pandemic has opened many people’s eyes to innovation.”